2024 Helius medical technologies - Helius Medical Technologies is a neurotech company focused on neurological wellness. The Company’s purpose is to develop, license and acquire unique and non-invasive platform technologies that ...

 
NEWTOWN, Pa., Nov. 30, 2023 (GLOBE NEWSWIRE) -- Helius Medical Technologies, Inc. (Nasdaq:HSDT) (“Helius” or the “Company”), a neurotech company focused on delivering a novel therapeutic .... Helius medical technologies

Aug 15, 2022 · Helius Medical Technologies is a leading neurotech company in the medical device field focused on neurologic deficits using non-implantable platform technologies that amplify the brain’s ability ... Sep 21, 2023 · Helius Medical Technologies is a leading neurotech company in the medical device field focused on neurologic deficits using non-implantable platform technologies that amplify the brain’s ability ... Helius Medical Technologies is a leading neurotech company in the medical device field focused on neurologic deficits using non-implantable platform technologies that amplify the brain’s ability ...Helius Medical Technologies (NASDAQ: NASDAQ:HSDT) is a tiny microcap with a $14.51m market capitalization that $100m in volume has transacted through in the past month.NEWTOWN, Pa., Nov. 30, 2023 (GLOBE NEWSWIRE) -- Helius Medical Technologies, Inc. (Nasdaq:HSDT) (“Helius” or the “Company”), a neurotech company focused on delivering a novel therapeutic neuromodulation approach for balance and gait deficits, today announced that Dane Andreeff, President and Chief. November 30, 2023.Jul 27, 2023 · About Helius Medical Technologies, Inc. Helius Medical Technologies is a leading neurotech company in the medical device field focused on neurologic deficits using non-implantable platform technologies that amplify the brain’s ability to compensate and promotes neuroplasticity, aiming to improve the lives of people dealing with neurologic ... Nov 24, 2023 · Helius Medical Technologies, Inc. to Release Third Quarter 2023 Financial Results on November 9, 2023; Announces Extended Cash Runway into Q2 2024. -- Expects to report Q3 revenues in range of $140 - $150 thousand, reflecting the expected decrease in U.S. sales with the conclusion of the Patient Therapy Access Program (PTAP) on June 30, 2023 Helius Medical Technologies is a leading neurotech company in the medical device field focused on neurologic deficits using orally applied technology platform that amplifies the brain’s ability ...Helius Medical Technologies is a leading neurotech company in the medical device field focused on neurologic deficits using non-implantable platform technologies that amplify the brain’s ability ...Aug 5, 2022 · Helius Medical Technologies is a neurotech company focused on neurological wellness. The Company’s purpose is to develop, license and acquire unique and non-invasive platform technologies that ... Previously, Mr. Buckman served as chief executive officer and chairman of Pathway Medical Technologies, Inc, a medical device company focused on treatment of peripheral arterial disease from September 2008 to February 2012; as chief executive officer of Devax, Inc, a developer and manufacturer of drug-eluting stents from December 2006 to ... NEWTOWN, Pa., Sept. 05, 2023 (GLOBE NEWSWIRE) -- Helius Medical Technologies, Inc. (Nasdaq:HSDT) (“Helius” or the “Company”), a neurotech company focused on …A Helius Medical Technologies medical device that stimulates the brain by sending electrical stimulation to the tongue has received FDA clearance for multiple sclerosis patients. The company says ...At Helius, we pride ourselves on being at the forefront of developing technology that is essential in addressing the needs of neurological disorders that effect movement and coordination. The Science The Scientific Theory: Improve Impaired Function by Stimulating Cranial Nerves via the TongueDec 1, 2023 · Helius Medical Technologies, Inc. to Release Third Quarter 2023 Financial Results on November 9, 2023; Announces Extended Cash Runway into Q2 2024. GlobeNewswire Nov 2, 2023 9:05pm. Helius Medical Technologies, Inc. (NASDAQ:HSDT) Q3 2023 Earnings Call Transcript November 12, 2023 Operator: Good day, everyone. My name is Chelsea, and I will be your conference operator. At this ...Helius Medical Technologies is a leading neurotech company in the medical device field focused on neurologic deficits using orally applied technology platform that amplifies the brain’s ability ...Delaware. 001-38445. 36-4787690 (State or other jurisdiction. of incorporation) (Commission File Number) (IRS Employer. Identification No.) 642 Newtown Yardley Road, Suite 100. Newtown, PA. 18940Delaware. 001-38445. 36-4787690 (State or other jurisdiction. of incorporation) (Commission File Number) (IRS Employer. Identification No.) 642 Newtown Yardley Road, Suite 100. Newtown, PA. 18940About Helius Medical Technologies, Inc. Helius Medical Technologies is a leading neurotech company in the medical device field focused on neurologic deficits using non-implantable platform technologies that amplify the brain’s ability to compensate and promote neuroplasticity, improving the lives of people dealing with neurologic diseases.About Helius Medical Technologies, Inc.Helius Medical Technologies is a leading neurotech company in the medical device field focused on neurologic deficits using orally applied technology ...About Helius Medical Technologies, Inc. Helius Medical Technologies is a leading neurotech company in the medical device field focused on neurologic deficits using non-implantable platform technologies that amplify the brain’s ability to compensate and promotes neuroplasticity, aiming to improve the lives of people dealing with neurologic ... Helius Medical Technologies plans to use the proceeds for the stock sale to conduct clinical testing of the non-invasive technology it is developing to amplify the brain’s ability to heal itself.Helius Medical Technologies is a leading neurotech company in the medical device field focused on neurologic deficits using an orally applied technology platform that amplifies the brain’s ...Helius Medical Technologies, Inc. continues to be at the forefront of neurological wellness technology, with a focus on developing non-invasive and innovative solutions to improve the lives of patients with neurological challenges.Who Owns Helius Medical Technologies, Inc. (HSDT) Helius Medical Technologies, Inc. is a neurological technology company …One of the biggest reasons senior citizens end up in the hospital is because of a fall in the home. If you’re worried about losing your independence, then a medical alert system can help.Helius Medical Technologies is a leading neurotech company in the medical device field focused on neurologic deficits using non-implantable platform technologies that amplify the brain’s ability ...Sep 21, 2023 · About Helius Medical Technologies, Inc. Helius Medical Technologies is a leading neurotech company in the medical device field focused on neurologic deficits using non-implantable platform technologies that amplify the brain’s ability to compensate and promote neuroplasticity, improving the lives of people dealing with neurologic diseases. Apr 26, 2022 · Helius Medical Technologies is a leading neurotech company in the medical device field focused on neurologic deficits using non-implantable platform technologies that amplify the brain’s ability ... Helius Medical Technologies is a leading neurotech company in the medical device field focused on neurologic deficits using orally applied technology platform that amplifies the brain’s ability ...Helius Medical Technologies is a leading neurotech company in the medical device field focused on neurologic deficits using non-implantable platform technologies that amplify the brain’s ability ...Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days: Yes ☒ …Helius Medical Technologies Inc. Watch list NEW Set a price target alert After Hours Last Updated: Oct 6, 2023 7:24 p.m. EDT Delayed quote $ 8.55 -0.16 -1.84% After Hours …Helius Medical Technologies, In. Daily – Vickers Top Insider Picks for 11/30/2023 The Vickers Top Insider Picks is a daily report that utilizes a proprietary algorithm to identify 25 companies ...Re: Registration Statement on Form S-8 . Ladies and Gentlemen: We have acted as counsel to Helius Medical Technologies, Inc., a Delaware corporation (the “Company”), in connection with the preparation and filing with the Securities and Exchange Commission (the “Commission”) of a Registration Statement on Form S-8 (the “Registration …Ethical considerations involve researchers who undertake studies of human behavior, medical advances or technological devices, while taking into account how humans may feel about the potential outcomes of the research.Nov 17, 2022 · Earnings Estimate Revisions for Helius Medical Technologies, Inc. For the fiscal year ending December 2022, this company is expected to earn -$1.75 per share, which is a change of 76.3% from the ... Previously, Mr. Buckman served as chief executive officer and chairman of Pathway Medical Technologies, Inc, a medical device company focused on treatment of peripheral arterial disease from September 2008 to February 2012; as chief executive officer of Devax, Inc, a developer and manufacturer of drug-eluting stents from December 2006 to ...Nov 24, 2023 · Helius Medical Technologies GAAP EPS of -$1.31 misses by $0.15, revenue of $0.26M beats by $0.16M SA News Mon, Mar. 14, 2022. Helius Medical rallies on issuance of U.S. Patent for wireless PoNS Helius Medical Technologies is a leading neurotech company in the medical device field focused on neurologic deficits using non-implantable platform technologies that amplify the brain’s ability ...NEWTOWN, Pa., Aug. 02, 2023 (GLOBE NEWSWIRE) -- Helius Medical Technologies, Inc. (NASDAQ: HSDT) (“Helius” or the “Company”), a neurotech company focused on …Helius Medical Technologies is a neurotech company focused on neurological wellness. The Company’s purpose is to develop, license and acquire unique and non-invasive platform technologies that amplify the brain’s ability to heal itself.Apple announced several things yesterday, but ResearchKit, the company's new medical research and health platform, is clearly the technology with the most potential to actually improve people's lives. Services like it are already at work ar...Aug 7, 2023 · Helius Medical Technologies is a leading neurotech company in the medical device field focused on neurologic deficits using non-implantable platform technologies that amplify the brain’s ability ... Helius Medical Technologies is a leading neurotech company in the medical device field focused on neurologic deficits using orally applied technology platform that amplifies the brain’s ability ...Nov 30, 2023 · Helius Medical Technologies GAAP EPS of -$0.06 beats by $0.06, revenue of $0.25M beats by $0.06M. November 30, 2023 | Tomorrow Investor (Ad) The Only Practical Solution to the World’s Looming Energy Crisis. There’s just one problem: There are more plans for new uses of nuclear than there is uranium to fuel the plants! Helius Medical Technologies GAAP EPS of -$0.09 beats by $0.02, revenue of $0.11M misses by $0.17M SA News Thu, May 11 Helius Medical Technologies, Inc. (HSDT) Q4 2022 Earnings Call TranscriptHelius Medical Technologies is a leading neurotech company in the medical device field focused on neurologic deficits using non-implantable platform technologies that amplify the brain’s ability ...ROSEN, A TOP RANKED LAW FIRM, Announces Filing of Securities Class Action Lawsuit Against Helius Medical Technologies, Inc.; Encourages Investors with Losses in Excess of $100K to Contact the Firm ...Mar 6, 2023 · Helius Medical Technologies is a leading neurotech company in the medical device field focused on neurologic deficits using non-implantable platform technologies that amplify the brain’s ability ... Helius Medical Technologies is a leading neurotech company in the medical device field focused on neurologic deficits using non-implantable platform technologies that amplify the brain’s ability to compensate and promote neuroplasticity, improving the lives of people dealing with neurologic diseases. The Company’s first commercial product ...Helius Medical Technologies is a leading neurotech company in the medical device field focused on neurologic deficits using non-implantable platform technologies that amplify the brain’s ability ...Jul 12, 2022 · Helius Medical Technologies is a leading neurotech company in the medical device field focused on neurologic deficits using non-implantable platform technologies that amplify the brain’s ability ... Helius Medical Technologies is a leading neurotech company in the medical device field focused on neurologic deficits using non-implantable platform technologies that amplify the brain’s ability ...Helius Medical Technologies is a leading neurotech company in the medical device field focused on neurologic deficits using non-implantable platform technologies that amplify the brain’s ability ...Aug 7, 2023 · Helius Medical Technologies is a leading neurotech company in the medical device field focused on neurologic deficits using non-implantable platform technologies that amplify the brain’s ability ... Helius Medical Technologies, Inc., a neurotechnology company, focuses on developing, licensing, and acquiring non-implantable technologies for the treatment of symptoms caused by neurological disease or trauma. The company’s product is Portable Neuromodulation Stimulator, a non-surgical medical device intended for use as a short …Helius Medical Technologies is a leading neurotech company in the medical device field focused on neurologic deficits using orally applied technology platform that amplifies the brain’s ability to engage physiologic compensatory mechanisms and promote neuroplasticity, improving the lives of people dealing with neurologic diseases. …Sep 28, 2023 · Helius Medical Technologies is a leading neurotech company in the medical device field focused on neurologic deficits using orally applied technology platform that amplifies the brain’s ability ... Ex. 10.3 . Form for U.S. Option Grants . Helius Medical Technologies, Inc. Stock Option Grant Notice (2018 Omnibus Incentive Plan) Helius Medical Technologies, Inc. (the “Company”), pursuant to its 2018 Omnibus Incentive Plan (the “Plan”), hereby grants to Optionholder an option to purchase the number of shares of the Company’s Common …Helius Technologies has an overall rating of 4.3 out of 5, based on over 238 reviews left anonymously by employees. 87% of employees would recommend working at Helius Technologies to a friend and 81% have a positive outlook for the business. This rating has decreased by -3% over the last 12 months.View Helius Medical Technologies, Inc HSDT investment & stock information. Get the latest Helius Medical Technologies, Inc HSDT detailed stock quotes, stock data, Real-Time ECN, charts, stats and ...Helius Medical Technologies, Inc. Class A Common Stock (DE) (HSDT) Stock Quotes - Nasdaq offers stock quotes & market activity data for US and global markets.Helius Medical Technologies is a leading neurotech company in the medical device field focused on neurologic deficits using non-implantable platform technologies that amplify the brain’s ability ...Helius Medical Technologies is a leading neurotech company in the medical device field focused on neurologic deficits using non-implantable platform technologies that amplify the brain’s ability ...Helius Medical Technologies, Inc. Class A Common Stock (DE) (HSDT) Stock Quotes - Nasdaq offers stock quotes & market activity data for US and global markets.Medical assistants are an important part of the healthcare industry, providing vital support to physicians and other medical professionals. But how much do medical assistants make? The answer depends on a variety of factors, including exper...Helius Medical Technologies is a leading neurotech company in the medical device field focused on neurologic deficits using non-implantable platform technologies that amplify the brain’s ability ...As of March 2015, Theranos is a private company and does not have a public stock symbol. The medical technology company has a partnership with the public company, Walgreens, which has a stock symbol of WAG on Nasdaq.Nov 13, 2023 · Helius Medical Technologies, Inc. (NASDAQ:HSDT) Q3 2023 Earnings Call Transcript November 12, 2023 Operator: Good day, everyone. My name is Chelsea, and I will be your conference operator. At this ... Welcome to the fourth quarter and year-end 2022 Earnings Conference Call for Helius Medical Technologies. This is Michelle Bilski of Insight Communications, Investor Relations for Helius. With me ...May 11, 2023 · About Helius Medical Technologies, Inc. Helius Medical Technologies is a leading neurotech company in the medical device field focused on neurologic deficits using non-implantable platform technologies that amplify the brain’s ability to compensate and promotes neuroplasticity, aiming to improve the lives of people dealing with neurologic ... As of September 30, 2023, we had $6.6 million in cash and no debt and $4 million in proceeds receivable from warrant exercises as of September 30, 2023, and we expect our cash runway to extend ...Helius Medical Technologies is a leading neurotech company in the medical device field focused on neurologic deficits using non-implantable platform technologies that amplify the brain’s ability ...The Investor Relations website contains information about Helius Medical Technologies, Inc.'s business for stockholders, potential investors, and financial analysts.NEWTOWN, Pa., Aug. 10, 2023 (GLOBE NEWSWIRE) -- Helius Medical Technologies, Inc. (Nasdaq:HSDT) (“Helius” or the “Company”), a neurotech company focused on delivering a novel therapeutic neuromodulation approach for balance and gait deficits, today announced results for the quarter ended June 30, 2023.One of the biggest reasons senior citizens end up in the hospital is because of a fall in the home. If you’re worried about losing your independence, then a medical alert system can help.Helius Medical Technologies, Inc., a neurotechnology company, focuses on developing, licensing, and acquiring non-implantable technologies for the treatment of symptoms caused by neurological disease or trauma. The company’s product is Portable Neuromodulation Stimulator, a non-surgical medical device intended for use as a short …Nov 24, 2023 · Helius Medical Technologies, Inc. (NASDAQ:HSDT) announced its earnings results on Thursday, November, 9th. The company reported ($5.49) EPS for the quarter. The firm earned $0.14 million during the quarter. Helius Medical Technologies had a negative net margin of 1,602.40% and a negative trailing twelve-month return on equity of 232.74%. His experience spans established medical device technologies as well as new novel technologies including AI. Mr. Picciano joined Helius Medical, Inc in late 2018 and serves as the senior vice president of product development, regulatory affairs, and quality. He has helped attain PoNS US FDA breakthrough device designations in multiple sclerosis ... About Helius Medical Technologies, Inc. Helius Medical Technologies is a leading neurotech company in the medical device field focused on neurologic deficits using orally applied technology platform that amplifies the brain’s ability to engage physiologic compensatory mechanisms and promote neuroplasticity, improving the lives of people ...As the healthcare industry continues to evolve, it’s important for medical facilities to have access to reliable and efficient technology. GE Healthcare Systems is a leading provider of medical equipment and solutions that can help improve ...Helius has studied the PoNS® to determine whether its use in combination Research - Helius Medical Technologies Our Research includes Helius-sponsored Clinical Trials and future PoNS Therapy studies on neurological diseases and disorders, such as stroke, multiple sclerosis and cerebral palsy. Helius Medical Technologies is a leading neurotech company in the medical device field focused on neurologic deficits using non-implantable platform technologies that amplify the brain’s ability ...Helius Medical Technologies, Inc. HSDT shares are trading higher on Tuesday after the company gained compliance with all applicable Nasdaq listing criteria. The Details: Helius Medical ...On August 31, 2023, Helius Medical Technologies, Inc. (the “Company”) received formal notification (the “Notification”) from The Nasdaq Stock Market LLC (“Nasdaq”) confirming that the Company has regained compliance with Nasdaq Listing Rule 5550(a)(2), which requires issuers listed on The Nasdaq Capital Market to maintain a …Helius Medical Technologies is a leading neurotech company in the medical device field focused on neurologic deficits using non-implantable platform technologies that amplify the brain’s ability ...Apple announced several things yesterday, but ResearchKit, the company's new medical research and health platform, is clearly the technology with the most potential to actually improve people's lives. Services like it are already at work ar...Helius Medical Technologies is a leading neurotech company in the medical device field focused on neurologic deficits using non-implantable platform technologies that amplify the brain’s ability ...Nov 24, 2023 · Helius Medical Technologies GAAP EPS of -$1.31 misses by $0.15, revenue of $0.26M beats by $0.16M SA News Mon, Mar. 14, 2022. Helius Medical rallies on issuance of U.S. Patent for wireless PoNS Nov 13, 2023 · Helius Medical Technologies, Inc. (NASDAQ:HSDT) Q3 2023 Earnings Call Transcript November 12, 2023 Operator: Good day, everyone. My name is Chelsea, and I will be your conference operator. At this ... Helius medical technologies

Helius Medical Technologies is a leading neurotech company in the medical device field focused on neurologic deficits using non-implantable platform technologies that amplify the brain’s ability .... Helius medical technologies

helius medical technologies

DELAWARE. 001-38445. 36-4787690 (State or Other Jurisdiction. of Incorporation) (Commission File Number) (IRS Employer. Identification No.) 642 Newtown Yardley Road, Suite 100About Helius Medical Technologies, Inc. Helius Medical Technologies is a leading neurotech company in the medical device field focused on neurologic deficits using orally applied technology platform that amplifies the brain’s ability to engage physiologic compensatory mechanisms and promote neuroplasticity, improving the lives of people ...Helius Medical Technologies, Inc. is a neurotech company in the medical device industry that focuses on neurological wellness. The firm develops, licenses and acquires non-invasive platform ...Helius Medical Technologies GAAP EPS of -$0.06 beats by $0.06, revenue of $0.25M beats by $0.06M. November 30, 2023 | Tomorrow Investor (Ad) The Only Practical Solution to the World’s Looming Energy Crisis. There’s just one problem: There are more plans for new uses of nuclear than there is uranium to fuel the plants!Helius Medical Technologies is a publicly traded company on the NASDAQ (HSDT) in the United States. Visit the About page to see how our company has …Chief Financial Officer. Mr. Mathiesen is an accomplished senior executive and director of public and privately held companies with broad experience in the biopharmaceutical, medical device, semiconductor capital equipment, and water filtration markets. Mr. Mathiesen has served as director and audit committee chair of Panbela Therapeutics, Inc ...Helius Medical Technologies is a leading neurotech company in the medical device field focused on neurologic deficits using non-implantable platform technologies that amplify the brain’s ability ...Sep 5, 2023 · Helius Medical Technologies is a leading neurotech company in the medical device field focused on neurologic deficits using an orally applied technology platform that amplifies the brain’s ... Nov 2, 2023 · Helius Medical Technologies is a leading neurotech company in the medical device field focused on neurologic deficits using orally applied technology platform that amplifies the brain’s ability ... May 11, 2023 · About Helius Medical Technologies, Inc. Helius Medical Technologies is a leading neurotech company in the medical device field focused on neurologic deficits using non-implantable platform technologies that amplify the brain’s ability to compensate and promotes neuroplasticity, aiming to improve the lives of people dealing with neurologic ... Earnings for Helius Medical Technologies are expected to grow in the coming year, from ($8.73) to ($6.26) per share. Helius Medical Technologies has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, March 14th, 2024 based off prior year's report dates. Read More.Nov 24, 2023 · Helius Medical Technologies, Inc. to Release Third Quarter 2023 Financial Results on November 9, 2023; Announces Extended Cash Runway into Q2 2024. -- Expects to report Q3 revenues in range of $140 - $150 thousand, reflecting the expected decrease in U.S. sales with the conclusion of the Patient Therapy Access Program (PTAP) on June 30, 2023 About Helius Medical Technologies, Inc. Helius Medical Technologies is a leading neurotech company in the medical device field focused on neurologic deficits using non-implantable platform technologies that amplify the brain’s ability to compensate and promote neuroplasticity, improving the lives of people dealing with neurologic diseases.Do you have unused medical equipment lying around your house? Are you looking for a way to donate it to those in need? If so, this guide is for you. Here, we’ll discuss where to donate your unused medical equipment and how to do it.The non-emergency medical transportation (NEMT) industry plays a critical role in ensuring that individuals with limited mobility have access to necessary healthcare services. As technology continues to advance, it is also shaping the role ...C/O HELIUS MEDICAL TECHNOLOGIES INC. 642 NEWTOWN YARDLEY ROAD SUITE 100 (Street) NEWTOWN: PA: 18940 (City) (State) (Zip) 2. Issuer Name and Ticker or Trading Symbol HELIUS MEDICAL TECHNOLOGIES, INC. [ HSDT] 5. Relationship of Reporting Person(s) to Issuer (Check all applicable) X:About Helius Medical Technologies, Inc.Helius Medical Technologies is a leading neurotech company in the medical device field focused on neurologic deficits using orally applied technology ...It’s not uncommon for people to struggle to pay their medical bills, and it’s certainly nothing to be ashamed of. But it’s a good idea to be proactive from the outset if you can. Here are 10 things you can do to improve your situation.Helius Medical Technologies, In. Daily – Vickers Top Insider Picks for 11/30/2023 The Vickers Top Insider Picks is a daily report that utilizes a proprietary algorithm to identify 25 companies ...Helius Medical Technologies is a leading neurotech company in the medical device field focused on neurologic deficits using non-implantable platform technologies that amplify the brain’s ability ...Helius Medical Technologies, Inc.’s Post Helius Medical Technologies, Inc. 2,527 followers 2h Report this post Do you want to know how our company actively engages with the broader community? ...Nov 24, 2023 · Helius Medical Technologies GAAP EPS of -$1.31 misses by $0.15, revenue of $0.26M beats by $0.16M SA News Mon, Mar. 14, 2022. Helius Medical rallies on issuance of U.S. Patent for wireless PoNS Helius Medical Technologies is a leading neurotech company in the medical device field focused on neurologic deficits using non-implantable platform technologies that amplify the brain’s ability ...Get the latest Helios Technologies Inc (HLIO) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and investment decisions.Helius Medical Technologies, Inc. (NASDAQ:HSDT) Q4 2021 Earnings Conference Call March 14, 2022 5:00 PM ET. Company Participants. Michelle Bilski - In-Site Communications, IR.About Helius Medical Technologies, Inc. Helius Medical Technologies is a leading neurotech company in the medical device field focused on neurologic deficits using non-implantable platform technologies that amplify the brain’s ability to compensate and promote neuroplasticity, improving the lives of people dealing with neurologic diseases.Nov 30, 2023 · Helius Medical Technologies GAAP EPS of -$0.06 beats by $0.06, revenue of $0.25M beats by $0.06M. November 30, 2023 | Tomorrow Investor (Ad) The Only Practical Solution to the World’s Looming Energy Crisis. There’s just one problem: There are more plans for new uses of nuclear than there is uranium to fuel the plants! Helius Medical Technologies is a neurotech company focused on neurological wellness. The Company’s purpose is to develop, license and acquire unique and non-invasive platform technologies that ...Helius Medical Technologies is a leading neurotech company in the medical device field focused on neurologic deficits using orally applied technology platform that amplifies the brain’s ability to engage physiologic compensatory mechanisms and promote neuroplasticity, improving the lives of people dealing with neurologic diseases. The Company ...Mar 23, 2023 · Helius Medical Technologies is a leading neurotech company in the medical device field focused on neurologic deficits using non-implantable platform technologies that amplify the brain’s ability ... Helius Medical Technologies is a leading neurotech company in the medical device field focused on neurologic deficits using orally applied technology platform that amplifies the brain’s ability ...Helius Medical Technologies is a leading neurotech company in the medical device field focused on neurologic deficits using non-implantable platform technologies that amplify the brain’s ability ...We would like to show you a description here but the site won’t allow us.Helius Medical Technologies, Inc. to Release Third Quarter 2023 Financial Results on November 9, 2023; Announces Extended Cash Runway into Q2 2024. -- Expects to report Q3 revenues in range of $140 - $150 thousand, reflecting the expected decrease in U.S. sales with the conclusion of the Patient Therapy Access Program (PTAP) on June 30, 2023NEWTOWN, Pa., Sept. 13, 2023 (GLOBE NEWSWIRE) -- Helius Medical Technologies, Inc. (Nasdaq:HSDT) (“Helius” or the “Company”), a neurotech company focused on delivering a novel therapeutic neuromodulation approach for balance and gait deficits, today announced that Antonella Favit-Van Pelt, M.D., Ph.D., Helius’ Chief Medical Officer, will present...Jun 20, 2023 · About Helius Medical Technologies, Inc. Helius Medical Technologies is a leading neurotech company in the medical device field focused on neurologic deficits using non-implantable platform technologies that amplify the brain’s ability to compensate and promote neuroplasticity, improving the lives of people dealing with neurologic diseases. Jan 3, 2023 · About Helius Medical Technologies, Inc. Helius Medical Technologies is a leading neurotech company in the medical device field focused on neurologic deficits using non-implantable platform technologies that amplify the brain’s ability to compensate and promote neuroplasticity, improving the lives of people dealing with neurologic diseases. Aug 10, 2023 · About Helius Medical Technologies, Inc. Helius Medical Technologies is a leading neurotech company in the medical device field focused on neurologic deficits using non-implantable platform technologies that amplify the brain’s ability to compensate and promotes neuroplasticity, aiming to improve the lives of people dealing with neurologic ... Helius Medical Technologies Inc is a neurological research company. The Company explores neuroplasticity, electrotactile stimulation and neuromodulation. Address. 41 University Drive Suite 400 ...About Helius Medical Technologies, Inc. Helius Medical Technologies is a leading neurotech company in the medical device field focused on neurologic deficits using non-implantable platform technologies that amplify the brain’s ability to compensate and promote neuroplasticity, improving the lives of people dealing with neurologic diseases.Helius brings together the world’s best talent to succeed in our ongoing mission. Together, we work passionately to develop and deliver easy-to-use technology for neurological wellness. If you want to join us in our mission, we want to hear from you. Email your letter of interest and resume to [email protected]. Apr 17, 2023 · Helius Medical Technologies is a leading neurotech company in the medical device field focused on neurologic deficits using non-implantable platform technologies that amplify the brain’s ability ... Nov 9, 2023 · Helius Medical Technologies is a leading neurotech company in the medical device field focused on neurologic deficits using orally applied technology platform that amplifies the brain’s ability ... Get the latest Helius Medical Technologies Inc (HSDT) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and investment decisions. Helius Medical Technologies is a leading neurotech company in the medical device field focused on neurologic deficits using non-implantable platform …Helius Technologies | 52,011 followers on LinkedIn. Estd. in 2006 | a TechnoPro Group company | [email protected] | Our Story Established in 2006 in Singapore – and …Nov 9, 2023 · Helius Medical Technologies is a leading neurotech company in the medical device field focused on neurologic deficits using orally applied technology platform that amplifies the brain’s ability ... Dec 1, 2023 · A high-level overview of Helius Medical Technologies, Inc. (HSDT) stock. Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and investment tools. On February 16, 2020, Mr. Thomas Griffin notified the Board of Directors (the “Board”) of Helius Medical Technologies, Inc. (the “Company”) of his intent not to run for reelection at the Company’s 2020 annual meeting of stockholders (the “Annual Meeting”). His term as director of the Company will conclude at the Annual Meeting. Mr.Aug 23, 2022 · Helius Medical Technologies, Inc., (“Helius”), is a neurotech company in the medical device industry, focused on neurological wellness. Helius’ origin stems from the early 1990s, and the ... Sep 21, 2023 · About Helius Medical Technologies, Inc. Helius Medical Technologies is a leading neurotech company in the medical device field focused on neurologic deficits using non-implantable platform technologies that amplify the brain’s ability to compensate and promote neuroplasticity, improving the lives of people dealing with neurologic diseases. Jan 26, 2022 · Helius Medical Technologies is a leading neurotech company in the medical device field focused on neurologic deficits using non-implantable platform technologies that amplify the brain’s ability ... Helius is a leading neurotech company in the medical device field focused on neurologic deficits using non-implantable platform technologies that amplify the brain’s ability to compensate and promote neuroplasticity, improving the lives of people dealing with neurologic diseases. Our Origin Due to rapid developments in technology, many people are now able to visit their doctors and other healthcare providers without ever leaving their homes. This form of remote medical meeting is known as telemedicine, and it’s one of the fast...The non-emergency medical transportation (NEMT) industry plays a critical role in ensuring that individuals with limited mobility have access to necessary healthcare services. As technology continues to advance, it is also shaping the role ...DELAWARE. 001-38445. 36-4787690 (State or Other Jurisdiction. of Incorporation) (Commission File Number) (IRS Employer. Identification No.) 642 Newtown Yardley Road, Suite 100. Newtown, PA. 18940Helius Medical Technologies is a leading neurotech company in the medical device field focused on neurologic deficits using non-implantable platform technologies that amplify the brain’s ability ...Apple announced several things yesterday, but ResearchKit, the company's new medical research and health platform, is clearly the technology with the most potential to actually improve people's lives. Services like it are already at work ar...Helius Medical Technologies, Inc. (NASDAQ:HSDT) announced its earnings results on Thursday, November, 9th. The company reported ($5.49) EPS for the quarter. The firm earned $0.14 million during the quarter. Helius Medical Technologies had a negative net margin of 1,602.40% and a negative trailing twelve-month return on equity of 232.74%.Nov 30, 2023 · Helius Medical Technologies is a leading neurotech company in the medical device field focused on neurologic deficits using orally applied technology platform that amplifies the brain’s ability ... NEWTOWN, Pa., Aug. 05, 2022 (GLOBE NEWSWIRE) -- Helius Medical Technologies, Inc. (Nasdaq: HSDT) (“Helius” or the “Company”), a neurotech company focused on …At Helius, we pride ourselves on being at the forefront of developing technology that is essential in addressing the needs of neurological disorders that effect movement and coordination. The Science The Scientific Theory: Improve Impaired Function by Stimulating Cranial Nerves via the TongueDELAWARE. 001-38445. 36-4787690 (State or Other Jurisdiction. of Incorporation) (Commission File Number) (IRS Employer. Identification No.) 642 Newtown Yardley Road, Suite 100Helius Medical Technologies is a leading neurotech company in the medical device field focused on neurologic deficits using non-implantable platform technologies that amplify the brain’s ability ...Helius Medical Technologies, Inc. is a neurotech company in the medical device field. It is focused on neurologic deficits using orally applied technology platform that amplifies the brainâ s ability to engage physiologic compensatory mechanisms enhancing the lives of people dealing with neurologic diseases. Nov 24, 2023 · Helius Medical Technologies, Inc. to Release Third Quarter 2023 Financial Results on November 9, 2023; Announces Extended Cash Runway into Q2 2024. -- Expects to report Q3 revenues in range of $140 - $150 thousand, reflecting the expected decrease in U.S. sales with the conclusion of the Patient Therapy Access Program (PTAP) on June 30, 2023 Helius Medical Technologies is a leading neurotech company in the medical device field focused on neurologic deficits using orally applied technology platform that amplifies the brain’s ability ...Jun 20, 2023 · About Helius Medical Technologies, Inc. Helius Medical Technologies is a leading neurotech company in the medical device field focused on neurologic deficits using non-implantable platform technologies that amplify the brain’s ability to compensate and promote neuroplasticity, improving the lives of people dealing with neurologic diseases. Helius Medical Technologies is a leading neurotech company in the medical device field focused on neurologic deficits using non-implantable platform technologies that amplify the brain’s ability ...About Helius Medical Technologies, Inc. Helius Medical Technologies is a neurotech company focused on neurological wellness. The Company’s purpose is to develop, license and acquire unique and non-invasive platform technologies that …Helius Medical Technologies Inc does not have a meaningful P/E due to negative earnings over the last 12 trailing months. Helius Medical Technologies Inc’s trailing 12-month revenue is $0.9 million with a % profit margin. Year-over-year quarterly sales growth most recently was 200.0%.We would like to show you a description here but the site won’t allow us.Helius Medical Technologies, Inc. (NASDAQ:HSDT) Q4 2021 Earnings Conference Call March 14, 2022 5:00 PM ET. Company Participants. Michelle Bilski - In-Site Communications, IR.Jan 23, 2023 · About Helius Medical Technologies, Inc. Helius Medical Technologies is a leading neurotech company in the medical device field focused on neurologic deficits using non-implantable platform technologies that amplify the brain’s ability to compensate and promotes neuroplasticity, aiming to improve the lives of people dealing with neurologic ... Exhibit 10.2. Employment Agreement . THIS EMPLOYMENT AGREEMENT (this “Agreement”) by and between Helius Medical Technologies, Inc., a Delaware corporation (the “Company”), and Jeffrey S. Mathiesen (the “Executive”) is entered into by the Company and the Executive and made effective as of June 14, 2021 (the “Effective Date”).. Recitals ...The C1 is a wearable, closed-loop, neurotechnology device, driven by a smartphone, that will support the brain to auto-calibrate its activity patterns by reading brain rhythms and using software algorithms to translate dominant frequencies into the medium of sound, in real time. The C1 leverages two important findings about brain function and ...Helius Medical Technologies, Inc. Class A Common Stock (DE) (HSDT) Stock Quotes - Nasdaq offers stock quotes & market activity data for US and global markets.. Wells fargo 529